Dynavax Technologies Corp. Company Profile (NASDAQ:DVAX)

About Dynavax Technologies Corp.

Dynavax Technologies Corp. logoDynavax Technologies Corporation (Dynavax) is a clinical-stage biopharmaceutical company. The Company uses toll-like receptor (TLR) biology to discover and develop vaccines and therapeutics. Its development programs are focused on vaccines and cancer immunotherapy. The Company's lead vaccine product candidate is HEPLISAV-B, an investigational adult hepatitis B vaccine, which combines its TLR9 agonist adjuvant and recombinant hepatitis B surface antigen (rHBsAg). Its lead cancer immunotherapy candidate is SD-101, a C Class CpG TLR9 agonist is selected for characteristics optimal for treatment of cancer, including high interferon induction. Its SD-101 clinical program is intended to assess the preliminary efficacy of SD-101 in a range of tumors and in combination with a range of treatments. Its advanced inflammatory disease candidate is AZD1419. Its pipeline of product candidates for cancer immunotherapy includes DV281 and CpG-Nanoparticles, which are in the preclinical stage.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: DVAX
  • CUSIP: 26815810
Key Metrics:
  • Previous Close: $11.06
  • 50 Day Moving Average: $14.34
  • 200 Day Moving Average: $16.12
  • 52-Week Range: $10.14 - $29.86
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -6.14
  • P/E Growth: 0.00
  • Market Cap: $425.78M
  • Outstanding Shares: 38,497,000
  • Beta: 2.51
Profitability:
  • Net Margins: -2,068.75%
  • Return on Equity: -64.43%
  • Return on Assets: -55.61%
Debt:
  • Current Ratio: 5.21%
  • Quick Ratio: 5.21%
Additional Links:
Companies Related to Dynavax Technologies Corp.:

Analyst Ratings

Consensus Ratings for Dynavax Technologies Corp. (NASDAQ:DVAX) (?)
Ratings Breakdown: 3 Hold Ratings, 2 Buy Ratings
Consensus Rating:Hold (Score: 2.40)
Consensus Price Target: $26.84 (142.63% upside)

Analysts' Ratings History for Dynavax Technologies Corp. (NASDAQ:DVAX)
Show:
DateFirmActionRatingPrice TargetDetails
9/6/2016William BlairReiterated RatingBuy$45.00View Rating Details
9/7/2016RBC Capital MarketsReiterated RatingSector Perform$16.00View Rating Details
9/6/2016Cowen and CompanyReiterated RatingOutperform$45.00View Rating Details
9/2/2016S&P Equity ResearchBoost Price Target$11.28 -> $16.01View Rating Details
4/27/2016Royal Bank Of CanadaDowngradeOutperform -> Sector Perform$48.00 -> $17.00View Rating Details
4/27/2016JPMorgan Chase & Co.DowngradeOverweight -> Neutral$29.00 -> $22.00View Rating Details
(Data available from 9/26/2014 forward)

Earnings

Earnings History for Dynavax Technologies Corp. (NASDAQ:DVAX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/3/2016        
8/5/2016Q2($0.68)($0.75)$1.58 million$2.65 millionViewN/AView Earnings Details
5/9/2016Q1($0.63)($0.70)$627.00 million$942.00 millionViewN/AView Earnings Details
3/8/2016Q4($0.75)($0.70)$1.15 million$0.69 millionViewN/AView Earnings Details
11/5/2015Q3($0.78)($0.82)$1.65 million$1.20 millionViewN/AView Earnings Details
8/7/2015Q2($1.00)($0.80)$3.05 million$1.55 millionViewN/AView Earnings Details
5/7/2015($0.95)($0.97)ViewN/AView Earnings Details
3/5/2015($1.06)($0.85)ViewN/AView Earnings Details
11/5/2014Q314($0.09)($0.11)$2.50 million$2.21 millionViewN/AView Earnings Details
8/7/2014Q214($0.06)($0.09)$2.26 million$3.05 millionViewN/AView Earnings Details
5/5/2014($0.06)($0.05)ViewN/AView Earnings Details
3/10/2014Q413($0.07)($0.09)$1.56 million$2.80 millionViewN/AView Earnings Details
11/7/2013Q313($0.10)($0.09)$1.83 million$2.93 millionViewN/AView Earnings Details
7/29/2013Q2 2013($0.10)($0.09)$2.91 million$3.40 millionViewN/AView Earnings Details
5/6/2013Q113($0.11)($0.11)$2.40 million$2.10 millionViewN/AView Earnings Details
3/1/2013Q4 2012($0.11)$11.40 million$1.80 millionViewN/AView Earnings Details
11/1/2012Q312($0.08)($0.10)$5.00 million$2.90 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Dynavax Technologies Corp. (NASDAQ:DVAX)
Current Year EPS Consensus Estimate: $-2.96 EPS
Next Year EPS Consensus Estimate: $-1.80 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.52)($0.52)($0.52)
Q2 20161($0.68)($0.68)($0.68)
Q3 20161($0.74)($0.74)($0.74)
Q4 20161($0.73)($0.73)($0.73)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Dynavax Technologies Corp. (NASDAQ:DVAX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Dynavax Technologies Corp. (NASDAQ:DVAX)
Insider Ownership Percentage: 2.00%
Institutional Ownership Percentage: 83.82%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/28/2016Robert JanssenVPBuy1,452$13.68$19,863.36View SEC Filing  
5/20/2016Eddie GrayCEOBuy2,750$15.57$42,817.50View SEC Filing  
5/12/2016Robert JanssenVPBuy1,000$15.12$15,120.00View SEC Filing  
8/14/2014Eddie GrayCEOBuy25,000$1.49$37,250.00View SEC Filing  
10/30/2013Peggy V PhillipsDirectorBuy93,023$1.08$100,464.84View SEC Filing  
9/14/2012Jennifer LewVPSell18,750$4.53$84,937.50View SEC Filing  
9/13/2012Robert CoffmanVPSell8,000$4.52$36,160.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Dynavax Technologies Corp. (NASDAQ:DVAX)
DateHeadline
News Icon2 Biotech Stocks News And Price Trends: Dynavax Technologies ... - The Voice Registrar (NASDAQ:DVAX)
voiceregistrar.com - September 26 at 4:54 PM
News IconTime To Put On The Watch List? - Dynavax Technologies Corporation (NASDAQ:DVAX), CorMedix, Inc. (NYSEMKT ... - The Voice Registrar (NASDAQ:DVAX)
voiceregistrar.com - September 23 at 9:44 AM
insidermonkey.com logoDynavax Technologies Corp (DVAX): Glenhill Advisors Adds to Its Position - Insider Monkey (blog) (NASDAQ:DVAX)
www.insidermonkey.com - September 21 at 5:14 PM
News IconDynavax Technologies Corp (DVAX): Glenhill Advisors Adds to Its Position (NASDAQ:DVAX)
feedproxy.google.com - September 20 at 10:05 AM
News IconActive biotech company shares in the news: Dynavax Technologies Corporation (NASDAQ:DVAX), Agios ... - The Voice Registrar (NASDAQ:DVAX)
voiceregistrar.com - September 19 at 9:22 AM
finance.yahoo.com logoHow one investor is playing Dynavax (NASDAQ:DVAX)
finance.yahoo.com - September 14 at 4:47 PM
News IconShares Going Lower in Trade: Dynavax Technologies Corporation (NASDAQ:DVAX) - Post News (NASDAQ:DVAX)
www.kentuckypostnews.com - September 14 at 8:52 AM
News IconInvestor News: Dynavax Technologies Corporation (NASDAQ:DVAX) faces Investigation over potential Violations of Securities Laws (NASDAQ:DVAX)
www.groundreport.com - September 13 at 9:35 AM
istreetwire.com logoMomentum Stocks: Coca-Cola European Partners Plc (CCE), Dynavax Technologies Corporation (DVAX), CarMax Inc ... - iStreetWire (NASDAQ:DVAX)
istreetwire.com - September 12 at 9:39 AM
investornewswire.com logoDynavax Technologies Corporation (NASDAQ:DVAX) Expects Sales Of $173.98 - Investor Newswire (NASDAQ:DVAX)
www.investornewswire.com - September 10 at 4:26 PM
seekingalpha.com logoDynavax Technologies Could Capture Majority Share In The Hepatitis B Vaccination Market (NASDAQ:DVAX)
seekingalpha.com - September 10 at 9:18 AM
News IconBiotech Stocks Worth Chasing: Dynavax Technologies Corporation (DVAX), Navidea Biopharmaceuticals, Inc (NAVB) - National Daily Press (NASDAQ:DVAX)
www.nationaldailypress.com - September 9 at 4:34 PM
News IconBiotech Stocks Worth Chasing: Dynavax Technologies Corporation (DVAX), Navidea Biopharmaceuticals, Inc (NAVB) - The Independent Republic (NASDAQ:DVAX)
theindependentrepublic.com - September 9 at 9:32 AM
News IconThe Sell-side Consensus is in on Dynavax Technologies Corporation (NASDAQ:DVAX); Earnings & Target Updates - National Daily Press (NASDAQ:DVAX)
www.nationaldailypress.com - September 9 at 9:32 AM
News IconBiotech Stocks Worth a Closer Look: Dynavax Technologies (NASDAQ:DVAX), Navidea Biopharmaceuticals ... - The Voice Registrar (NASDAQ:DVAX)
voiceregistrar.com - September 9 at 9:32 AM
finance.yahoo.com logoShareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Dynavax Technologies ... - Yahoo Finance (NASDAQ:DVAX)
finance.yahoo.com - September 8 at 8:32 AM
News IconBiotech Top Gainers- CoLucid Pharmaceuticals (NASDAQ:CLCD), Dynavax Technologies (NASDAQ:DVAX) - Seneca Globe (NASDAQ:DVAX)
www.senecaglobe.com - September 8 at 8:32 AM
prnewswire.com logoShareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Dynavax Technologies ... - PR Newswire (press release) (NASDAQ:DVAX)
www.prnewswire.com - September 7 at 8:00 AM
News IconHot Stock Alert - Dynavax Technologies Corporation's (DVAX) - Hot Stocks Point (NASDAQ:DVAX)
www.hotstockspoint.com - September 7 at 8:00 AM
News IconShareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Dynavax Technologies Corporation (DVAX) (NASDAQ:DVAX)
ih.advfn.com - September 6 at 4:36 PM
fool.com logoWhy Dynavax Technologies Is Gaining Back 27% Today (NASDAQ:DVAX)
www.fool.com - September 6 at 3:49 PM
investorplace.com logoDynavax Technologies Corporation (DVAX) Injected With 20%-Plus Gains (NASDAQ:DVAX)
investorplace.com - September 6 at 11:01 AM
streetinsider.com logoDynavax (DVAX) Announces Regulatory Update for HEPLISAV-B (NASDAQ:DVAX)
www.streetinsider.com - September 6 at 9:35 AM
rttnews.com logoDynavax Technologies Corp. (DVAX) Plummeted After FDA Cancelled Meeting (NASDAQ:DVAX)
www.rttnews.com - September 6 at 9:35 AM
News IconDynavax Technologies Corporation (NASDAQ:DVAX) Decline Is A Big Opportunity (NASDAQ:DVAX)
streetregister.com - September 6 at 9:35 AM
biz.yahoo.com logoDYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:DVAX)
biz.yahoo.com - September 6 at 9:35 AM
News IconDynavax Technologies Shares Tumble to 7-Year Low (NASDAQ:DVAX)
larampadinapoli.com - September 5 at 9:19 AM
marketwired.com logoDynavax Provides Regulatory Update on HEPLISAV-B (NASDAQ:DVAX)
www.marketwired.com - September 5 at 9:19 AM
capitalcube.com logoDynavax Technologies Corp. breached its 50 day moving average in a Bearish Manner : DVAX-US : September 5, 2016 (NASDAQ:DVAX)
www.capitalcube.com - September 5 at 9:19 AM
thecountrycaller.com logoDynavax Technologies Corporation (DVAX): Shares Plunge after FDA Meeting Cancellation - TCC (NASDAQ:DVAX)
www.thecountrycaller.com - September 4 at 4:24 PM
News IconDynavax Sinks 32% As FDA Cancels Its AdComm Meeting (NASDAQ:DVAX)
www.talkmarkets.com - September 3 at 4:24 PM
nasdaq.com logoNotable Friday Option Activity: DVAX, RUTH, GOOG (NASDAQ:DVAX)
www.nasdaq.com - September 3 at 4:24 PM
thecountrycaller.com logoDynavax Technologies Corporation (DVAX): Shares Plunge after FDA Meeting Cancellation (NASDAQ:DVAX)
www.thecountrycaller.com - September 3 at 4:24 PM
News IconWhy Dynavax Technologies Shares Crashed 32% Today (NASDAQ:DVAX)
billingsgazette.com - September 3 at 4:24 PM
finance.yahoo.com logoEQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Dynavax Technologies Corporation - DVAX (NASDAQ:DVAX)
finance.yahoo.com - September 3 at 9:29 AM
finance.yahoo.com logoINVESTOR ALERT: Goldberg Law PC Announces an Investigation of Claims against Dynavax Technologies Corporation and Advises Investors to Contact the Firm (NASDAQ:DVAX)
finance.yahoo.com - September 3 at 9:29 AM
benzinga.com logoCorrection: The FDA Cancelled Dynavax's Hep-B Drug ADCOM Meeting - Benzinga (NASDAQ:DVAX)
www.benzinga.com - September 2 at 4:40 PM
thestreet.com logoDynavax Technologies (DVAX) Stock Plummets on Cancelled FDA Meeting (NASDAQ:DVAX)
www.thestreet.com - September 2 at 4:40 PM
bloomberg.com logoDynavax Plummets After FDA Cancels Advisory Panel for Vaccine (NASDAQ:DVAX)
www.bloomberg.com - September 2 at 4:40 PM
247wallst.com logoBristol-Myers, Verifone Dive into Friday’s 52-Week Low Club (NASDAQ:DVAX)
247wallst.com - September 2 at 4:40 PM
feeds.benzinga.com logoThe FDA Just Blocked Approval On Dynavax's Hep-B Drug For The Second Time (NASDAQ:DVAX)
feeds.benzinga.com - September 2 at 1:39 PM
capitalcube.com logoETF’s with exposure to Dynavax Technologies Corp. : August 25, 2016 (NASDAQ:DVAX)
www.capitalcube.com - August 25 at 4:47 PM
benzinga.com logoDVAX: Insiders vs. Shorts (NASDAQ:DVAX)
www.benzinga.com - August 25 at 9:39 AM
thestreet.com logoDVAX April 2017 Options Begin Trading (NASDAQ:DVAX)
www.thestreet.com - August 22 at 4:46 PM
nasdaq.com logoNoteworthy Monday Option Activity: DVAX, AMGN, NDSN (NASDAQ:DVAX)
www.nasdaq.com - August 22 at 4:46 PM
stocksdaily.net logoCan Dynavax Technologies Corporation (NASDAQ:DVAX) Meet Analysts Expectations? - Stocks Daily (NASDAQ:DVAX)
www.stocksdaily.net - August 21 at 4:26 PM
investornewswire.com logoAnalysts See Sales Of $173.98 For Dynavax Technologies Corporation (NASDAQ:DVAX) - Investor Newswire (NASDAQ:DVAX)
www.investornewswire.com - August 20 at 4:41 PM
finance.yahoo.com logoDYNAVAX TECHNOLOGIES CORP Financials (NASDAQ:DVAX)
finance.yahoo.com - August 20 at 4:41 PM
stocksdaily.net logoWill Dynavax Technologies Corporation (NASDAQ:DVAX) Surprise Analysts This Quarter? - Stocks Daily (NASDAQ:DVAX)
www.stocksdaily.net - August 15 at 10:11 PM
capitalcube.com logoETF’s with exposure to Dynavax Technologies Corp. : August 12, 2016 (NASDAQ:DVAX)
www.capitalcube.com - August 12 at 4:43 PM

Social

Dynavax Technologies Corp. (NASDAQ:DVAX) Chart for Monday, September, 26, 2016


Last Updated on 9/26/2016 by MarketBeat.com Staff